More about

Ocular Gene Therapy

News
May 22, 2024
1 min read
Save

Clinical Trials at the Summit brings together global retina experts

Clinical Trials at the Summit brings together global retina experts

In June, retina experts from around the world will convene in Park City, Utah, to discuss ongoing clinical trials, best trial practices and recent data at Clinical Trials at the Summit.

News
May 16, 2024
2 min watch
Save

VIDEO: Gene therapy shows promising disease control for wet AMD in clinical trials

VIDEO: Gene therapy shows promising disease control for wet AMD in clinical trials

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Carl D. Regillo, MD, discusses promising results for the Ixo-vec gene therapy for neovascular age-related macular degeneration.

News
May 15, 2024
1 min watch
Save

VIDEO: Gene therapy-associated uveitis must be mitigated to improve clinical trials

VIDEO: Gene therapy-associated uveitis must be mitigated to improve clinical trials

SEATTLE — In this Healio Video Perspective from the Retina World Congress, David Almeida, MD, MBA, PhD, discusses combating gene therapy-associated uveitis.

News
May 14, 2024
3 min watch
Save

VIDEO: Gene therapy improves visual acuity in patients with retinitis pigmentosa

VIDEO: Gene therapy improves visual acuity in patients with retinitis pigmentosa

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Christine Kay, MD, discusses MCO-010, a gene-agnostic therapy for patients with advanced retinitis pigmentosa.

News
May 13, 2024
3 min watch
Save

VIDEO: RGX-314 shows positive results for diabetic retinopathy at 1 year

VIDEO: RGX-314 shows positive results for diabetic retinopathy at 1 year

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Dilsher Dhoot, MD, shares 1 year results from the phase 2 ALTITUDE trial investigating RGX-314 gene therapy for the treatment of diabetic retinopathy.

News
April 10, 2024
2 min read
Save

ABBV-RGX-314 well tolerated with sustained anti-VEGF protein expression in wet AMD

ABBV-RGX-314 well tolerated with sustained anti-VEGF protein expression in wet AMD

Subretinal delivery of ABBV-RGX-314 gene therapy demonstrated safety and sustained anti-VEGF protein expression at higher doses in patients with neovascular age-related macular degeneration, according to a study.

News
March 27, 2024
2 min read
Save

Gene therapy improves vision in patients with retinitis pigmentosa in phase 2b trial

Gene therapy improves vision in patients with retinitis pigmentosa in phase 2b trial

MCO-010 demonstrated positive topline results in vision improvement in patients with permanent and severe vision loss from advanced retinitis pigmentosa, according to a press release from Nanoscope Therapeutics.

News
March 25, 2024
1 min read
Save

Lumevoq shows sustained efficacy, safety 4 years after one-time LHON treatment

Lumevoq shows sustained efficacy, safety 4 years after one-time LHON treatment

Lumevoq demonstrated sustained efficacy and a positive safety profile at 4 years after a one-time injection of the gene therapy in patients with Leber hereditary optic neuropathy, according to a press release from GenSight Biologics.

News
March 09, 2024
2 min watch
Save

VIDEO: Delivery options for wet AMD gene therapy under investigation

VIDEO: Delivery options for wet AMD gene therapy under investigation

WAILEA, Hawaii — In this Healio Video Perspective from Retina 2024, Lejla Vajzovic, MD, FASRS, discusses developments in gene therapy for wet age-related macular degeneration.

News
February 29, 2024
1 min read
Save

PulseSight Therapeutics launches with focus on non-viral gene therapies

PulseSight Therapeutics launches with focus on non-viral gene therapies

PulseSight Therapeutics, which is developing non-viral gene therapies for retinal diseases, has launched with seed financing from Pureos Bioventures and ND Capital, according to a press release.

View more